NYSEAMERICAN:NSPRInspireMD Stock Price, Forecast & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for InspireMD.

InspireMD is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for InspireMD.

InspireMD Inc (NYSEAMERICAN:NSPR) released its quarterly earnings data on Tuesday, May, 12th. The medical equipment provider reported ($0.43) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.63) by $0.20. The medical equipment provider earned $1.03 million during the quarter, compared to analyst estimates of $1 million. View InspireMD's earnings history.

Shares of InspireMD reverse split before market open on Monday, April 1st 2019. The 1-50 reverse split was announced on Tuesday, March 26th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 29th 2019. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 2 shares after the split.

1 equities research analysts have issued 12-month price objectives for InspireMD's stock. Their forecasts range from $2.00 to $2.00. On average, they expect InspireMD's share price to reach $2.00 in the next twelve months. This suggests a possible upside of 325.5% from the stock's current price. View analysts' price targets for InspireMD.

Media coverage about NSPR stock has trended somewhat positive on Sunday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. InspireMD earned a news impact score of 1.3 on InfoTrie's scale. They also gave headlines about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about InspireMD.

Some companies that are related to InspireMD include Deltex Medical Group (DEMG), Zecotek Photonics (ZMS), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other InspireMD investors own include Palatin Technologies (PTN), NovaBay Pharmaceuticals (NBY), TransEnterix (TRXC), Inovio Pharmaceuticals (INO), Catalyst Pharmaceuticals (CPRX), Novavax (NVAX), AVEO Pharmaceuticals (AVEO), Biocept (BIOC), Curis (CRIS) and Gilead Sciences (GILD).

InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR."

Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NSPR stock can currently be purchased for approximately $0.47.

InspireMD has a market capitalization of $2.04 million. InspireMD employs 43 workers across the globe.

The official website for InspireMD is www.inspiremd.com.

InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553.